Psilocybin mushrooms are fungi that contain the psychoactive compounds psilocybin and psilocin. There are multiple colloquial terms for psilocybin mushrooms, the most common being shrooms and magic mushrooms.[1][2] Biological genera containing psilocybin mushrooms include Agrocybe, Conocybe, Copelandia, Galerina, Gerronema, Gymnopilus, Hypholoma, Inocybe, Mycena, Panaeolus, Pluteus, and Psilocybe. There are approximately 190 species of psilocybin mushrooms and most of them fall in the genus Psilocybe.
Contents |
There is some archaeological evidence for the use of psyilocybin-containing mushrooms in ancient times. Several mesolithic rock paintings from Tassili n'Ajjer (a prehistoric North African site identified with the Capsian culture) have been identified by author Giorgio Samorini as possibly depicting the shamanic use of mushrooms, possibly Psilocybe.[3] Hallucinogenic species of Psilocybe have a history of use among the native peoples of Mesoamerica for religious communion, divination, and healing, from pre-Columbian times up to the present day. Mushroom-shaped statuettes found at archaeological sites seem to indicate that ritual use of hallucinogenic mushrooms is quite ancient.[4] Mushroom stones and motifs have been found in Mayan temple ruins in Guatemala,[5] though there is considerable controversy as to whether these objects indicate the use of hallucinogenic mushrooms or whether they had some other significance with the mushroom shape being simply a coincidence. More concretely, a statuette dating from ca. 200 AD and depicting a mushroom strongly resembling Psilocybe mexicana was found in a west Mexican shaft and chamber tomb in the state of Colima. Hallucinogenic Psilocybe were known to the Aztecs as teonanácatl (literally "divine mushroom" - agglutinative form of teó (god, sacred) and nanácatl (mushroom) in Náhuatl) and were reportedly served at the coronation of the Aztec ruler Moctezuma II in 1502. Aztecs and Mazatecs referred to psilocybin mushrooms as genius mushrooms, divinatory mushrooms, and wondrous mushrooms, when translated into English.[6] Bernardino de Sahagún reported ritualistic use of teonanácatl by the Aztecs, when he traveled to Central America after the expedition of Hernán Cortés.
After the Spanish conquest, Catholic missionaries campaigned against the "pagan idolatry," and as a result the use of hallucinogenic plants and mushrooms like other pre-Christian traditions was quickly suppressed.[5] The Spanish believed the mushroom allowed the Aztecs and others to communicate with "devils". In converting people to Catholicism, the Spanish pushed for a switch from teonanácatl to the Catholic sacrament of the Eucharist. Despite this history, in some remote areas, the use of teonanácatl has remained.
The first mention of hallucinogenic mushrooms in the Western medicinal literature appeared in the London Medical and Physical Journal in 1799: a man had served Psilocybe semilanceata mushrooms that he had picked for breakfast in London's Green Park to his family. The doctor who treated them later described how the youngest child "was attacked with fits of immoderate laughter, nor could the threats of his father or mother refrain him."[7]
In 1955, Valentina and R. Gordon Wasson became the first Westerners to actively participate in an indigenous mushroom ceremony. The Wassons did much to publicize their discovery, even publishing an article on their experiences in Life in 1957.[8] In 1956 Roger Heim identified the hallucinogenic mushroom that the Wassons had brought back from Mexico as Psilocybe, and in 1958, Albert Hofmann first identified psilocin and psilocybin as the active compounds in these mushrooms.
Inspired by the Wassons' Life article, Timothy Leary traveled to Mexico to experience hallucinogenic mushrooms firsthand. Upon returning to Harvard in 1960, he and Richard Alpert started the Harvard Psilocybin Project, promoting psychological and religious study of psilocybin and other hallucinogenic drugs. After Leary and Alpert were dismissed by Harvard in 1963, they turned their attention toward promoting the psychedelic experience to the nascent hippie counterculture.
The popularization of entheogens by Wasson, Leary, authors Terence McKenna and Robert Anton Wilson, and others has led to an explosion in the use of hallucinogenic Psilocybe throughout the world. By the early 1970s, a number of psychoactive Psilocybe species were described from temperate North America, Europe, and Asia and were widely collected. Books describing methods of cultivating Psilocybe cubensis in large quantities were also published. The availability of hallucinogenic Psilocybe from wild and cultivated sources has made it among the most widely used of the hallucinogenic drugs.
At present, hallucinogenic mushroom use has been reported among a number of groups spanning from central Mexico to Oaxaca, including groups of Nahua, Mixtecs, Mixe, Mazatecs,[9] Zapotecs, and others. An important figure of mushroom usage in Mexico was Maria Sabina.
The effects of Psilocybin mushrooms come from psilocybin and psilocin. They do create short-term increases in tolerance of users, thus making it difficult to abuse them because the more often they are taken within a short period of time, the weaker the resultant effects are.[10] Poisonous (sometimes lethal) wild picked mushrooms can be easily mistaken for psilocybin mushrooms. When psilocybin is ingested, it is broken down to produce psilocin, which is responsible for the hallucinogenic effects.[10][11]
As with many psychedelic substances, the effects of psychedelic mushrooms are subjective and can vary considerably among individual users. The mind-altering effects of psilocybin-containing mushrooms typically last anywhere from 3 to 8 hours depending on dosage, preparation method, and personal metabolism. However, the effects can seem to last much longer because of psilocybin's ability to alter time perception.[12][13]
Some users suffer from hallucinogen persisting perception disorder although how many, and why, is unknown. Perceptual disturbances causing discomfort are rarely reported after using psylocybin, but they may be more likely if the drug is mixed with cannabis.[14] There have been reports of such disturbances lasting 5 years or more.[15] Magic mushrooms have also been controversially associated with long term effects such as panic attacks, depression and paranoid delusions.[16] On the other hand, magic mushrooms were rated as causing some of the least damage in the UK compared to other recreational drugs by experts in a study by the Independent Scientific Committee on Drugs.[17] Other researchers have said that the main chemical component (psilocybin) is "remarkably non-toxic to the body's organ systems", explaining that the risks are indirect: higher dosages are more likely to cause fear and may result in dangerous behavior.[18]
One study found that the most desirable results may come from starting with very low doses first, and trying slightly higher doses over months. The researchers explain that the peak experiences occur at quantities that are only slightly lower than a sort of anxiety threshold. Although risks of experiencing fear and anxiety increased somewhat consistently along with dosage and overall quality of experience, at dosages exceeding the individual's threshold, there was suddenly greater increases in anxiety than before. In other words, after finding the optimum dose, there are diminishing returns for using more (since risks of anxiety now increase at a greater rate).[18]
Noticeable changes to the audio, visual, and tactile senses may become apparent around thirty minutes to an hour after ingestion. These shifts in perception visually include enhancement and contrasting of colors, strange light phenomena (such as auras or "halos" around light sources), increased visual acuity, surfaces that seem to ripple, shimmer, or breathe; complex open and closed eye visuals of form constants or images, objects that warp, morph, or change solid colors; a sense of melting into the environment, and trails behind moving objects. Sounds seem to be heard with increased clarity; music, for example, can often take on a profound sense of cadence and depth. Some users experience synesthesia, wherein they perceive, for example, a visualization of color upon hearing a particular sound.[19]
As with other psychedelics such as LSD, the experience, or "trip," is strongly dependent upon set and setting. A negative environment could likely induce a bad trip, whereas a comfortable and familiar environment would allow for a pleasant experience. Many users find it preferable to ingest the mushrooms with friends, people they are familiar with, or people who are also 'tripping'.[20][21]
In 2006, the United States government funded a randomized and double-blinded study by Johns Hopkins University which studied the spiritual effects of psilocybin in particular. That is, they did not use mushrooms specifically (in fact, each individual mushroom piece can vary wildly in psilocybin and psilocin content[22]). The study involved 36 college-educated adults (average age of 46) who had never tried psilocybin nor had a history of drug use, and who had religious or spiritual interests. The participants were closely observed for eight-hour intervals in a laboratory while under the influence of psilocybin.[23]
One-third of the participants reported that the experience was the single most spiritually significant moment of their lives and more than two-thirds reported it was among the top five most spiritually significant experiences. Two months after the study, 79% of the participants reported increased well-being or satisfaction; friends, relatives, and associates confirmed this. They also reported anxiety and depression symptoms to be decreased or completely gone.
Despite highly controlled conditions to minimize adverse effects, 22% of subjects (8 of 36) had notable experiences of fear, some with paranoia. The authors, however, reported that all these instances were "readily managed with reassurance."[23]
There have been calls for medical investigation of the use of synthetic and mushroom-derived psilocybin for the development of improved treatments of various mental conditions, including chronic cluster headaches,[24] following numerous anecdotal reports of benefits. There are also several accounts of psilocybin mushrooms sending both obsessive-compulsive disorders ("OCD") and OCD-related clinical depression (both being widespread and debilitating mental health conditions) into complete remission immediately and for up to months at a time, compared to current medications which often have both limited efficacy[25] and frequent undesirable side-effects.[26] One such study states:
Dosage of mushrooms containing psilocybin depends on the potency of the mushroom (the total psilocybin and psilocin content of the mushrooms), which varies significantly both between species and within the same species, but is typically around 0.5-2% of the dried weight of the mushroom. A typical dose of the rather common species, Psilocybe cubensis, is approximately 1 to 2.5 grams,[27] while about 2.5 to 5 grams[27] dried mushroom material is considered a strong dose. Above 5 dried grams is often considered a heavy dose.
Name | Psilocybin [%] | Psilocin [%] | Baeocystin [%] | Total [%] |
---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The concentration of active psilocybin mushroom compounds varies not only from species to species, but also from mushroom to mushroom inside a given species, subspecies or variety. The same holds true even for different parts of the same mushroom. In the species Psilocybe samuiensis Guzmán, Bandala and Allen, the dried cap of the mushroom contains the most psilocybin at about 0.23%–0.90%.[32] The mycelia contain about 0.24%–0.32%.[32]
Psilocybin and psilocin are listed as Schedule I drugs under the United Nations 1971 Convention on Psychotropic Substances.[33] Schedule I drugs are deemed to have a high potential for abuse and are not recognized for medical use. However, psilocybin mushrooms are not covered by UN drug treaties.
From a letter, dated Sept 13, 2001, from Herbert Schaepe, Secretary of the UN International Narcotics Control Board, to the Dutch Ministry of Health:[34]
As you are aware, mushrooms containing the above substances are collected and used for their hallucinogenic effects. As a matter of international law, no plants (natural material) containing psilocine and psilocybin are at present controlled under the Convention on Psychotropic Substances of 1971. Consequently, preparations made of these plants are not under international control and, therefore, not subject of the articles of the 1971 Convention. It should be noted, however, that criminal cases are decided with reference to domestic law, which may otherwise provide for controls over mushrooms containing psilocine and psilocybin. As the Board can only speak as to the contours of the international drug conventions, I am unable to provide an opinion on the litigation in question.
Psilocybin mushrooms are regulated or prohibited in many countries, often carrying severe legal penalties (for example, the U.S. Psychotropic Substances Act, the UK Misuse of Drugs Act 1971 and Drugs Act 2005, and the Canadian Controlled Drugs and Substances Act).
Magic mushrooms in their fresh form still remain legal in some countries including Spain, Austria, and Canada. On November 29, 2008, The Netherlands announced it would ban the cultivation and use of psilocybin-containing fungi beginning December 1, 2008.[35] The UK ban on fresh mushrooms (dried ones were illegal as they were considered a psilocybin-containing preparation) introduced in 2005 came under much criticism, but was rushed through at the end of the 2001-2005 Parliament; until then magic mushrooms had been sold in the UK.
New Mexico appeals court ruled on June 14, 2005, that growing psilocybin mushrooms for personal consumption could not be considered "manufacturing a controlled substance" under state law. However it still remains illegal under federal law.[36][37]
|
|